(Q46542220)

23 December 2017

title

Effect of hepatic impairment on the multiple-dose pharmacokinetics of ranolazine sustained-release tablets (English)

1 reference

23 December 2017

1 reference

Hisham Abdallah

1

1 reference

23 December 2017

Markus Jerling

series ordinal

2

1 reference

23 December 2017

publication date

1 July 2005

1 reference

23 December 2017

The Journal of Clinical Pharmacology

published in

1 reference

23 December 2017

volume

45

1 reference

23 December 2017

page(s)

802-809

1 reference

23 December 2017

issue

7

1 reference

23 December 2017

Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276739

Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276739

Transection of the oesophagus for bleeding oesophageal varices

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276739

Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005276739

21 January 2018

Identifiers

DOI

10.1177/0091270005276739

1 reference

23 December 2017

release_xdxrogbnz5hcxo4bfrkbhpuj4q

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xdxrogbnz5hcxo4bfrkbhpuj4q

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

15951470

1 reference

23 December 2017